Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. Psoriatic arthritis is considered as seronegative spondyloarthropathies. The fact that it is Seronegative is that the blood tests negative for some factors that is present in rheumatoid arthritis. Spondyloarthropathy describes a group of conditions that all share common characteristics. First, there is a presence of arthritis that affects the spine. Second, inflammation occurs in ligaments, tendons and sometimes in other organs such as the eye.
DelveInsight’s, “Psoriatic arthritis Pipeline Insight, 2021” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Psoriatic arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/psoriatic-arthritis-pipeline-insight
Some of Psoriatic Arthritis Companies are:
DelveInsight’s Psoriatic Arthritis report covers around 35+ products under different phases of clinical development like
Some of Psoriatic Arthritis Therapies are:
Current Psoriatic Arthritis Treatment Scenario and Psoriatic Arthritis Emerging Therapies:
Table of Contents:
Introduction Executive Summary Psoriatic arthritis: Overview Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment Psoriatic arthritis – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Psoriatic arthritis companies’ collaborations, Licensing, Acquisition -Deal Value Trends Psoriatic arthritis Collaboration Deals Late Stage Products (Preregistration) • Comparative Analysis Tildrakizumab: Sun Pharma Global Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis BMS-986165: Bristol-Myers Squibb Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Apremilast: 3SBio Drug profiles in the detailed report….. Preclinical and Discovery stage Products • Comparative Analysis ALPN 101: Alpine Immune Sciences Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Psoriatic arthritis Key Companies Psoriatic arthritis Key Products Psoriatic arthritis- Unmet Needs Psoriatic arthritis- Market Drivers and Barriers Psoriatic arthritis- Future Perspectives and Conclusion Psoriatic arthritis Analyst Views Psoriatic arthritis Key Companies Appendix
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/psoriatic-arthritis-pipeline-insight